Heidi Lyng

Heidi Lyng is Professor at the Department of Physics, University of Oslo, leading research in Biophysics and Medical Physics. Her work bridges fundamental physics with clinical applications in oncology.

Her doctoral education focused on physics and medical applications. Postdoctoral training specialized in radiation oncology and imaging techniques.

Research Focus: Dr. Lyng's laboratory investigates tumor hypoxia quantification using advanced MRI techniques, develops predictive biomarkers for radiation therapy response, and explores metabolic targeting strategies in gynecological cancers. Current projects examine hypoxia-mediated treatment resistance mechanisms and AI-based prognostic modeling.

Recent publications demonstrate three key trends: 1) Validation of imaging biomarkers for hypoxia quantification across cancer types, 2) Integration of radiomics with molecular profiling for treatment personalization, and 3) Clinical translation of metabolic modulators like metformin in combination therapies. Collaborative studies span international cohorts with standardized imaging protocols.

The research group maintains active collaborations with Oslo University Hospital's Radiation Oncology department and participates in multinational consortia for validation of imaging biomarkers. Laboratory facilities include dedicated small-animal irradiation equipment and hypoxia imaging systems.